Quarterly report pursuant to Section 13 or 15(d)

Equity - Stock Based Compensation Expense (Details)

v3.24.2.u1
Equity - Stock Based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Temporary Equity and Stockholders' Deficiency        
Stock-based compensation expense $ 1,670 $ 231 $ 2,057 $ 617
Cost of goods sold        
Temporary Equity and Stockholders' Deficiency        
Stock-based compensation expense 111 8 140 23
Research and development        
Temporary Equity and Stockholders' Deficiency        
Stock-based compensation expense 69 24 93 73
Selling, general and administrative        
Temporary Equity and Stockholders' Deficiency        
Stock-based compensation expense $ 1,490 $ 199 $ 1,824 $ 521